IGF-1 is an important regulator of the myogenic program: low levels of IGF-1 are associated with muscle loss (sarcopenia), while ectopic expression of IGF-1 causes reversal of the sarcopenic phenotype (Musarò et al., 2001). This evidence concerns the gene IGF1 and sarcopenia.